Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joel E. Tepper, MD
UNC Lineberger Comprehensive Cancer Center
Study Chair - John S. MacDonald, MD
Beth Israel Comprehensive Cancer Center - West Side Campus
Study Chair - Michael G. Haddock, MD
Mayo Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
485 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pretoria Academic Hospital
Pretoria, South Africa
- Comprehensive Cancer Center at University of Alabama at Birmingham
Birmingham, Alabama, United States
- Mobile Infirmary Medical Center
Mobile, Alabama, United States
- Alaska Regional Hospital
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Foundation for Cancer Research and Education
Phoenix, Arizona, United States
- Ccop - Mayo Clinic Scottsdale Oncology Program
Scottsdale, Arizona, United States
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
Fort Smith, Arkansas, United States
- Alta Bates Comprehensive Cancer Center
Berkeley, California, United States
- Providence Saint Joseph Medical Center - Burbank
Burbank, California, United States
- Mills-Peninsula Health Services
Burlingame, California, United States
- Mount Diablo Regional Cancer Center
Concord, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- California Cancer Center - Woodward Park Office
Fresno, California, United States
- Marin Cancer Institute at Marin General Hospital
Greenbrae, California, United States
- Sutter Health Western Division Cancer Research Group
Greenbrae, California, United States
- Saint Rose Hospital
Hayward, California, United States
- Valley Memorial Hospital
Livermore, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center
Loma Linda, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Providence Holy Cross Cancer Center
Mission Hills, California, United States
- Memorial Medical Center Cancer Services
Modesto, California, United States
- Leavey Cancer Center at Northridge Hospital Medical Center
Northridge, California, United States
- Ccop - Bay Area Tumor Institute
Oakland, California, United States
- Highland General Hospital
Oakland, California, United States
- Summit Medical Center
Oakland, California, United States
- Palo Alto Medical Foundation
Palo Alto, California, United States
- Pomona Valley Hospital Medical Center
Pomona, California, United States
- Radiological Associates of Sacramento Medical Group, Inc.
Sacramento, California, United States
- University of California Davis Cancer Center
Sacramento, California, United States
- Naval Medical Center - San Diego
San Diego, California, United States
- California Pacific Medical Center - California Campus
San Francisco, California, United States
- J.C. Robinson, M.D. Regional Cancer Center
San Pablo, California, United States
- Ccop - Santa Rosa Memorial Hospital
Sana Rosa, California, United States
- Torrance Memorial Medical Center
Torrance, California, United States
- Sutter Solano Medical Center
Vallejo, California, United States
- Aurora Presbyterian Hospital
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Memorial Hospital Cancer Center
Colorado Springs, Colorado, United States
- Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 1998
- Primary completion
- 31 Oct 2005
- Completion
- 31 Dec 2016
- Last update posted
- 4 Jan 2017
- Registered enrollment
- 682
- Registry id
- NCT00003596
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.